Skip to main content
. Author manuscript; available in PMC: 2022 Jul 1.
Published in final edited form as: Am J Transplant. 2021 Jan 5;21(7):2399–2412. doi: 10.1111/ajt.16440

Table 2: Results of meta-regression analysis of MELD difference, waiting time, and post-LT biliary complications on 1-year overall patient survival.

Residual τ2 indicates whether, after including each moderator, heterogeneity exists due to the covariate being examined.

Outcome Measure Relative Risk [95% CI] Residual τ2 p- value
1-year patient survival
MELD difference -5.5 0.67 [0.51, 0.87] 0.0515 0.02
Time on Waitlist 0.94 [0.55,1.61] 0.0321 0.9
Biliary complications 0.83 [0.58,1.20] 0.0976 0.21